Ipca Pharmaceuticals Inc., USA, the wholly owned subsidiary of Mumbai-based pharmaceutical company Ipca Laboratories acquired an 80 percent stake in New Jersey-based Bayshore Pharmaceuticals LLC for $10 million. The acquisition will enable the parent company to commercialize its registered generics drug products in the U.S. market.
For the financial year ending December 31, 2017, Bayshore had a total income of $7.05 million.
